Toronto, Ontario – July 17, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and destroy cancer, announced today that it has appointed an experienced sales and marketing team to launch its next generation therapeutic laser.
The TLC-2000 therapeutic laser with patented Cell SensingTM technology, has the unique ability of being able to “sense” injured tissue and then simultaneously deliver a precise dose of laser energy to the area healing it, safer, faster and more effectively than any other competitive product on the market. Theralase expects that this next generation technology will revolutionize the therapeutic laser industry by providing healthcare practitioners with a technology that possesses the repeatability and reproducibility that has been lacking in the field, allowing Theralase the opportunity to catapult for the first time into mainstream medicine.
Theralase’s appointment of its new sales and marketing team coincides with the anticipated launch of the TLC-2000, pending Health Canada approval, expected 3Q2015.
David Smith, Director of Sales
David possesses 25 years’ experience at the executive level managing medical device sales in Canada, the U.S, and international markets. He has demonstrated a track record of success in previous senior sales positions with Eli Lilly, Baxter and Philips Healthcare. David’s educational background includes completion of an Executive Program for Strategic Sales Management from the Graduate School of Business, University of Chicago, as well as an undergraduate degree in Physical and Health Education from McMaster University.
Natasha Noble, Territory Sales Manager – British Columbia and North West USA
Natasha is an enthusiastic and highly motivated sales professional, who has been a top performer for over 6 years with Canon Canada Inc. and Actavis Pharmaceuticals. Recently joining the Company, she is motivated by the almost limitless opportunity made possible with the pending launch of the TLC-2000 technology, and is quickly demonstrating her high level of professionalism and selling skills in her new territory.
Gary Kazimer, Territory Sales Manager – Alberta, Saskatchewan and US Midwest
Gary is a highly accomplished sales manager in the sale of medical devices, who has consistently exceeded his revenue and sales targets in Western Canada over the last 5 years with Theralase. Gary previously worked 8 years in the aesthetic laser business and 15 years in the ophthalmic diagnostic Industry. Gary possesses a strong working knowledge of lasers that has allowed him to excel in his role with the Company.
Shawn Drew, Territory Sales Manager – Manitoba, Western Ontario and Northern US
Shawn’s hallmark has always been to put his customers first. As a human kinetics major hailing from the University of Guelph, he brings a strong scientific understanding of human physiology and anatomy. Through his dedication and building of long term clinical partnerships, Shawn has helped his customers achieve success both clinically and financially. Shawn prides himself on providing on-site training and shares his wealth of knowledge on best clinical practices with all his customers.
Kyle Shantz, Territory Sales Manager – Central and Eastern Ontario
Kyle is a results-oriented self-starter, who has a natural flair for sales coupled with a strong worth ethic. This combination has allowed Kyle to consistently achieve top sales performance in medical device sales. Kyle continues to demonstrate his top performance selling skills with outstanding results in his role at Theralase.
Stéphane Chaussé, Territory Sales Manager – Quebec and Atlantic Canada
Stéphane brings to the table over 16 years of experience selling medical devices in Eastern Canada. He is a results oriented sales professional with a proven record of accomplishment, both as a leader and as an individual performer. Coupled with his strong laser technology knowledge and work ethic, Stéphane is a natural fit with the organization to dramatically grow sales in the Quebec & Maritimes region.
Alan Chan, Director of Marketing
Alan brings over 25 years of marketing experience from the pharmaceutical and medical device industries, where he was in leadership positions launching several billion-dollar products in global markets. He was a pioneer in the creation of the medical aesthetics market, when he led the launch of Botox cosmetics and helped grow it to the billion dollar industry that it is today. Alan possesses the experience and vision to help Theralase command a dominant role in the therapeutic laser market with the launch of the TLC-2000.
Roxana Gonzales, Graphic & Web Designer
With a strong background in graphic design and a passion for photography and interactive technologies, Roxana is a creative thinker and a versatile designer who helps bring Theralase’s brand to life, ensuring all visual aspects of the marketing communications are consistent with the Theralase brand. Roxana brings over 8 years of professional design experience and online marketing to Theralase.
Rick Levine, Videographer
Rick has decades of experience both as an experienced marketer and performance artist, allowing him a strong artistic flair and eye for visual detail. As a key member of the marketing team, his mandate is to create and develop a growing library of video assets in the areas of operational and clinical training for healthcare practitioners, patient education and sales support.
Paul Grandy, Marketing Communications Coordinator
Paul has over 10 years of experience in communications and marketing strategy. He possesses strong experience in the development of rewarding partnerships with the medical industry and their related associations. Paul is creative and enthusiastic in everything he does and brings his years of experience developing content and marketing medical devices with Philips Healthcare to Theralase.
Sharon Opaski, Inside Sales Representative
Sharon is an enthusiastic and results-driven sales professional that has been with Theralase over the last 6 years. As a top performing Inside Sales Representative she has demonstrated an ability to successfully drive sales and generate leads for the sales team. Sharon brings over 20 years of top level sales and management experience from the retail sector to the Theralase team.
Marla Samuel, Inside Sales Representative
Marla has over ten years’ experience in the service industry cultivating business relationships and working within the holistic community as a Registered Nutritional Consultant and Diabetes Educator. She holds a Master’s degree in Science and is dedicated to helping the community live healthier lives with Theralase laser therapy.
Mike Mikati, Inside Sales Representative
Mike is the latest addition to the sales and marketing team, bringing 20 years of business development experience to the company. Educated in France and fluent in French and Arabic, Mike’ mandate will be to support the development and growth of Theralase’s business in Quebec, France and the Middle East.
About Theralase Technologies Inc.
Theralase Technologies Inc. (“Theralase®”) (TSXV: TLT) (TLTFF: OTC) in its Therapeutic Laser Technology Division designs, manufactures and markets patented super-pulsed laser technology indicated for the: elimination of pain, reduction of inflammation and dramatic acceleration of tissue healing for numerous nerve, muscle and joint conditions. Theralase’s Photo Dynamic Therapy Division researches and develops specially designed molecules called Photo Dynamic Compounds, which are able to localize to cancer cells and then when laser light activated, effectively destroy them.
Additional information is available at www.theralase.com and www.sedar.com .
Theralase Technologies Inc. was recognized as a TSX Venture 50® company in 2015. TSX Venture 50 is a trademark of TSX Inc. and is used under license.
This press release contains forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.
For More Information:
Michael Borovec
Director of Investor Relations
1.866.THE.LASE (843-5273) ext. 222
416.699.LASE (5273) ext. 222